Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration ; volume:21 ; number:1 ; day:1 ; month:10 ; year:2024 ; pages:1-12 ; date:12.2024
Journal of neuroinflammation ; 21, Heft 1 (1.10.2024), 1-12, 12.2024
- Creator
-
Dabouz, Rabah
Abram, Pénélope
Rivera, Jose Carlos
Chemtob, Sylvain
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-024-03229-x
- URN
-
urn:nbn:de:101:1-2412182113126.759745546110
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dabouz, Rabah
- Abram, Pénélope
- Rivera, Jose Carlos
- Chemtob, Sylvain
- SpringerLink (Online service)
Other Objects (12)
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Activation of a Quiescent Choroidal Neovascularization in a Patient with Age-Related Macular Degeneration
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Optical Coherence Tomography Prognostic Factors in Age-Related Macular Degeneration Patients with Peripapillary Choroidal Neovascularization
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Longitudinal Changes in Choroidal Thickness and Choroidal Vascularity Index in Age-Related Macular Degeneration
Age-related macular degeneration